Immune Design CS (IMDZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMDZ | TARA | OABI | ||
| Company | Immune Design CS | Artara Therapeutics Inc | Omniab Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.84 | 5.51 | 1.8900 | ||
| High | 5.85 | 5.51 | 1.9613 | ||
| Low | 5.84 | 5.21 | 1.8301 | ||
| Latest | 5.85 | 5.32 | 1.8500 | ||
| Change | unch | -0.28 | -0.1050 | ||
| % Change | unch | -5.00% | -5.37% | ||
| Volume | 103,800 | 874,076 | 231,959 | ||
| 20-Day Average Volume | 409,005 | 1,393,434 | 310,163 | ||
| Previous Close | 5.85 | 5.60 | 1.9550 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.84 | 6.18 | 1.7953 | ||
| 20-Day Raw Stochastic | 100.00% | 4.80% | 50.59% | ||
| 20-Day Relative Strength | 88.63 | 42.38 | 51.18 | ||
| Weighted Alpha | -20.50 | -1.37 | -27.95 | ||
| Today's Opinion | 88% Buy | 40% Buy | 88% Buy | ||
| Previous Opinion | 88% Buy | 40% Buy | 72% Buy | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/25/19 | -8.59% since 03/05/26 | -7.50% since 03/05/26 | ||
| Low | 5.84 on 04/01/19 | 5.21 on 03/12/26 | 1.8000 on 03/09/26 | ||
| High | 5.85 on 04/01/19 | 6.07 on 03/10/26 | 2.0350 on 03/10/26 | ||
| 1-Month | |||||
| %Chg | +0.34% since 03/01/19 | -18.53% since 02/12/26 | +9.47% since 02/12/26 | ||
| Low | 5.82 on 03/14/19 | 5.21 on 03/12/26 | 1.6700 on 03/02/26 | ||
| High | 5.85 on 04/01/19 | 7.50 on 02/23/26 | 2.0600 on 03/05/26 | ||
| 3-Month | |||||
| %Chg | +350.00% since 12/31/18 | -6.67% since 12/12/25 | -13.95% since 12/12/25 | ||
| Low | 1.22 on 01/03/19 | 4.72 on 01/16/26 | 1.6350 on 02/12/26 | ||
| High | 5.85 on 04/01/19 | 7.50 on 02/23/26 | 2.1700 on 12/15/25 | ||
| 6-Month | |||||
| %Chg | +73.08% since 10/01/18 | +69.43% since 09/12/25 | +12.80% since 09/12/25 | ||
| Low | 1.10 on 12/24/18 | 3.02 on 09/17/25 | 1.3000 on 11/05/25 | ||
| High | 5.85 on 04/01/19 | 7.82 on 11/24/25 | 2.2200 on 12/12/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 282,935 | 289,134 | 281,432 | ||
| Shares Outstanding, K | 48,365 | 51,631 | 143,955 | ||
| Annual Sales | 2,200,000 | 0 | 18,670,000 | ||
| Annual Net Income | -54,760,000 | -44,600,000 | -64,780,000 | ||
| Last Quarter Sales | 480,000 | 0 | 8,380,000 | ||
| Last Quarter Net Income | -13,600,000 | -13,260,000 | -14,180,000 | ||
| 60-Month Beta | 3.48 | 1.40 | 0.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.31 on 11/10/25 | -0.14 on 11/04/25 | ||
| Latest Earnings Date | 05/01/19 | 05/14/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||